Adage Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-341,578	Closed	-$42.9M	–	947
2025 Q2	$42.9M	Buy	+341,578	New	+$39.2M	0.07%	270
2022 Q3	–	Sell	-105,000	Closed	-$10.2M	–	1091
2022 Q2	$10.2M	Buy	105,000 +20,000	+24%	+$1.85M	0.02%	663
2022 Q1	$7.97M	Sell	85,000 -352,000	-81%	-$29.8M	0.02%	755
2021 Q4	$37.2M	Buy	+437,000	New	+$40.2M	0.07%	298
2019 Q4	–	Sell	-62,000	Closed	-$5.59M	–	748
2019 Q3	$5.59M	Buy	+62,000	New	+$5.79M	0.01%	618
2019 Q1	–	Sell	-8,000	Closed	-$571K	–	723
2018 Q4	$571K	Sell	8,000 -18,000	-69%	-$1.72M	﹤0.01%	689
2018 Q3	$3.2M	Sell	26,000 -126,000	-83%	-$14.3M	0.01%	661
2018 Q2	$14.9M	Buy	+152,000	New	+$13.6M	0.03%	478
2014 Q2	–	Sell	-136,286	Closed	-$2.19M	–	725
2014 Q1	$2.19M	Buy	+136,286	New	+$2.33M	0.01%	640